CP
CPRX icon

CenterBook Partners’s Catalyst Pharmaceutical CPRX Stock Holding History

CenterBook Partners’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,464
Closed -$1.13M – 676
2025
Q4 		$1.13M Buy
48,464
+36,556
+307% +$814K 0.06% 347
2025
Q3 		$235K Sell
11,908
-3,031
-20% -$62.3K 0.01% 536
2025
Q2 		$324K Buy
+14,939
New +$353K 0.02% 481
2023
Q4 		– Sell
-13,577
Closed -$159K – 408
2023
Q3 		$159K Buy
13,577
+2,259
+20% +$30.2K 0.02% 403
2023
Q2 		$152K Buy
+11,318
New +$163K 0.02% 397
2022
Q4 		– Sell
-26,231
Closed -$337K – 396
2022
Q3 		$337K Buy
+26,231
New +$311K 0.07% 325

Other funds holding CPRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM